Two Sigma Securities, LLC Abiomed Inc Call Options Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$242.49 - $301.46 $290,988 - $361,752	1,200 New	1,200 $295,000
Q1 2021 May 17, 2021	SELL	$285.92 - $355.13 $257,328 - $319,617	-900 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$251.88 - $324.2 $75,564 - $97,260	-300 Reduced 25.0%	900 $292,000
Q3 2020 Nov 16, 2020	SELL	$255.22 - $317.0 $76,566 - $95,100	-300 Reduced 20.0%	1,200 $332,000
Q2 2020 Sep 10, 2020	BUY	$141.4 - $257.09 $212,100 - $385,634	1,500 New	1,500 $362,000
Q1 2020 May 15, 2020	SELL	$130.51 - $196.01 $574,244 - $862,444	-4,400 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$159.31 - $223.54 $318,620 - $447,080	2,000 Added 83.33%	4,400 $751,000
Q1 2019 May 15, 2019	BUY	$276.39 - $362.25 $663,336 - $869,400	2,400 New	2,400 $685,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.